Abstract:Mitochondrial dynamics plays a critical role in maintaining healthy endothelial function, but whether the atherogenic advanced glycation end products (AGEs) can influence mitochondrial dynamics of endothelial cell remains unclear. AGE modified bovine serum albumin (AGE-BSA) was used as AGEs, primary human aortic endothelial cell line was multiplied, and divided into groups incubated with AGEs of different concentrations for different time. The expression of phosphatase and tensin homologue (PTEN)-induced putative kinase 1 (PINK1) was silenced with specific siRNA. Mitochondrial morphology of HAECs in each group was determined with transmission electron microscopy. Real time PCR method was used to detect the mRNA expression levels of mitochondrial dynamics regulatory genes mitofusin 1 (Mfn1), mitofusin 2 (Mfn2), optic atrophy 1 (Opa1), and dynamin-related protein 1 (Drp1) of HAECs, and western blot method was used to detect the protein expression levels of these regulatory genes. Specific antibody was used to block receptor for advanced glycation end products (RAGE). Treatment of different concentrations of AGEs, HAECs presented more granular mitochondrion, indicating AGEs promoted mitochondrial fission of HAECs remarkably. Silencing PINK1 induced mitochondrial fission in HAECs, and AGEs further promoted mitochondrial fragmentation in HAECs of PINK1 silenced. Different concentrations of AGEs down-regulated the mRNA and protein expression of mitochondrial pro-fusional genes Mfn1, Mfn2, Opa1, up-regulated the expression of mitochondrial pro-fissional gene Drp1, and both of the two phosphorylated Drp1 (p-ser-Drp1-616 and p-ser-Drp1-637) were increased. Time-dependent dynamic alterations of the expression levels of Mfn1, Mfn2, Opa1, and Drp1 were also found in HAECs stimulated with AGEs. Blocking RAGE with anti-RAGE inhibited AGEs induced mitochondrial fission and reversed AGEs induced expression changes of mitochondrial regulatory genes Drp1, Mfn1, Mfn2, and Opa1, indicating AGEs induced mitochondrial fission through RAGE in HAECs. In conclusion, AGEs may promote mitochondrial fission of HAECs through its receptor RAGE, silencing PINK1 induces mitochondrial fission, and AGEs further promote mitochondrial fragmentation in HAECs of PINK1 silenced. AGEs up-regulate the expression of mitochondrial pro-fissional gene Drp1 and down-regulate the expression of mitochondrial pro-fusional genes Mfn1, Mfn2, and Opa1 in HAECs.

The Role of RAGE, MAPK and NF-κB Pathway in the Advanced Glycation End-Products Induced HUVECs Dysfunction

Autophagy plays a protective role in advanced glycation end product-induced apoptosis of vascular endothelial cells

Erk And Akt Signaling Pathways Are Involved In Advanced Glycation End Product-Induced Autophagy In Rat Vascular Smooth Muscle Cells

Advanced Glycation End-Products Downregulate HoxA9EC Through Activation of Nuclear Factor Kappa B by Reciprocal Interaction

Advanced Glycation End Products Upregulates The Expression Of Connexin43 Via Erk Mapk And Pi3k/Akt Pathways In Human Endothelial Cells

AGEs Increased Migration and Inflammatory Responses of Adventitial Fibroblasts Via RAGE, MAPK and NF-κB Pathways

Nuclear Factor Kappa-B/Homeobox A9-Mediated Modulation of Leucine-Rich Repeat Flightless-Interacting Protein 1 Is Involved in Advanced Glycation End Product-Induced Endothelial Dysfunction

Advanced Glycation End Products Facilitate Proliferation and Reduce Early Apoptosis of Cardiac Microvascular Endothelial Cell Via PKCβ Signaling Pathway: Insight from Diabetic Cardiomyopathy

Advanced glycation end products depress function of endothelial progenitor cells via p38 and ERK 1/2 mitogen-activated protein kinase pathways

Advanced Glycation End Products Influence Mitochondrial Fusion-Fission Dynamics Through RAGE in Human Aortic Endothelial Cells.

Advanced Glycation Endproducts Increase EPC Apoptosis and Decrease Nitric Oxide Release Via MAPK Pathways

Advanced Glycation End Products Induce Actin Rearrangement and Subsequent Hyperpermeability in Endothelial Cells

Advanced Glycation End Products Induce Tubular Epithelial-Myofibroblast Transition through the RAGE-ERK1/2 MAP Kinase Signaling Pathway

Advanced glycosylation end products (AGEs) controls proliferation, invasion and permeability through orchestrating ARHGAP18/RhoA pathway in human umbilical vein endothelial cells

Effect of advanced glycation end products on expression of matrix metalloproteinases in human umbilical vein endothelial cells

Advanced Glycation End Products Increased Angiopoietin-1 Expression Via Oxidative Stress and NF-κB Pathways in Cultured NRK-49F Cells

AGEs/RAGE Promote Osteogenic Differentiation in Rat Bone Marrow-Derived Endothelial Progenitor Cells via MAPK Signaling

Advanced glycation end-products decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells

Mechanism of Advanced Glycation End Products-Stimulated Phosphorylation of ERM Protein in Human Umbilical Vein Endothelial Cells

AGEs/RAGE blockade downregulates Endothenin-1 (ET-1), mitigating Human Umbilical Vein Endothelial Cells (HUVEC) injury in deep vein thrombosis (DVT)

Advanced Glycation End Products Impair Function of Late Endothelial Progenitor Cells Through Effects on Protein Kinase Akt and Cyclooxygenase-2